Kose Samet, Mohamed Nur Adam
Department of Psychiatry and Behavioral Sciences, Mogadishu Somalia Turkey Recep Tayyip Erdogan Research and Training Hospital, Mogadishu, Somalia.
Department of Psychiatry, Basaksehir Cam Sakura City Hospital, Health Sciences University, Istanbul 34480, Türkiye.
Brain Sci. 2024 Jan 30;14(2):144. doi: 10.3390/brainsci14020144.
This study aimed to assess anxiety, depression, and sleep quality in kidney failure patients receiving hemodialysis (HD) in Somalia and examine the relationship between anxiety, depression, and sleep quality.
We conducted a study with 200 kidney failure patients on HD treatment for over 3 months. Participants completed sociodemographic questionnaires, the Patient Health Questionnaire-9 (PHQ-9), the Hospital Anxiety and Depression Scale (HADS), the Insomnia Severity Index (ISI), and the Pittsburgh Sleep Quality Index (PSQI).
Among the 200 participants (mean age = 52.3; SD = 14.13), 58.5% were men, 64% had CKD for 1-5 years, and 52.6% received HD for 1-5 years. Depressive symptoms were found in 61.5% (PHQ-9) and 37.5% (HADS depression subscale) of HD patients. Poor sleep quality (PSQI) was observed in 31.5% and significantly correlated with PHQ-9 ( = 0.633), HADS anxiety ( = 0.491), and HADS depression ( = 0.529). The ISI score correlated significantly with PHQ-9 ( = 0.611), HADS anxiety ( = 0.494), and HADS depression ( = 0.586). All PSQI components correlated with depression and anxiety, except sleep medication use. Hierarchical regression analysis revealed that HADS anxiety ( = 0.342) and HADS depression ( = 0.372) predicted ISI scores. HADS anxiety ( = 0.307) and HADS depression ( = 0.419) predicted PSQI scores.
Higher anxiety and depression levels negatively correlated with various dimensions of sleep quality in kidney failure patients. Early identification and appropriate management of these psychological disturbances are crucial for enhancing patients' overall quality of life.
本研究旨在评估索马里接受血液透析(HD)的肾衰竭患者的焦虑、抑郁和睡眠质量,并探讨焦虑、抑郁与睡眠质量之间的关系。
我们对200例接受HD治疗超过3个月的肾衰竭患者进行了一项研究。参与者完成了社会人口学问卷、患者健康问卷-9(PHQ-9)、医院焦虑抑郁量表(HADS)、失眠严重程度指数(ISI)和匹兹堡睡眠质量指数(PSQI)。
在200名参与者中(平均年龄=52.3;标准差=14.13),58.5%为男性,64%患有慢性肾脏病1-5年,52.6%接受HD治疗1-5年。HD患者中,61.5%(PHQ-9)和37.5%(HADS抑郁子量表)存在抑郁症状。31.5%的患者睡眠质量差(PSQI),且与PHQ-9(=0.633)、HADS焦虑(=0.491)和HADS抑郁(=0.529)显著相关。ISI评分与PHQ-9(=0.611)、HADS焦虑(=0.494)和HADS抑郁(=0.586)显著相关。除使用助眠药物外,PSQI的所有组成部分均与抑郁和焦虑相关。分层回归分析显示,HADS焦虑(=0.342)和HADS抑郁(=0.372)可预测ISI评分。HADS焦虑(=0.307)和HADS抑郁(=0.419)可预测PSQI评分。
肾衰竭患者较高的焦虑和抑郁水平与睡眠质量的各个维度呈负相关。早期识别和适当管理这些心理障碍对于提高患者的整体生活质量至关重要。